常染色体隐性多囊肾病和常染色体显性多囊肾病：近亲还是远亲？ - Suppr

Suppr

超能文献

ARPKD and ADPKD: first cousins or more distant relatives?

作者信息

Kaimori Jun-Ya, Germino Gregory G

出版信息

J Am Soc Nephrol. 2008 Mar;19(3):416-8. doi: 10.1681/ASN.2008010033. Epub 2008 Feb 13.

DOI:10.1681/ASN.2008010033

PMID:18272839

Abstract

摘要

相似文献

ARPKD and ADPKD: first cousins or more distant relatives?

J Am Soc Nephrol. 2008 Mar;19(3):416-8. doi: 10.1681/ASN.2008010033. Epub 2008 Feb 13.

Another cystic mystery solved.

Nat Genet. 2002 Mar;30(3):247-8. doi: 10.1038/ng0302-247.

Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Feb;35(2):93-9. doi: 10.3969/j.issn.1672-7347.2010.02.001.

Cilia and polycystic kidney disease.

Semin Cell Dev Biol. 2021 Feb;110:139-148. doi: 10.1016/j.semcdb.2020.05.003. Epub 2020 May 28.

Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.

J Am Soc Nephrol. 2013 Oct;24(10):1571-86. doi: 10.1681/ASN.2012111089. Epub 2013 Sep 5.

Recent advances in understanding ion transport mechanisms in polycystic kidney disease.

Clin Sci (Lond). 2021 Nov 12;135(21):2521-2540. doi: 10.1042/CS20210370.

Molecular basis of autosomal recessive polycystic kidney disease (ARPKD).

Adv Anat Pathol. 2008 Jan;15(1):54-8. doi: 10.1097/PAP.0b013e31815e5295.

Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).

Cell Tissue Res. 2006 Dec;326(3):671-85. doi: 10.1007/s00441-006-0226-0. Epub 2006 Jun 10.

Molecular genetics of ADPKD.

Contrib Nephrol. 1995;115:8-15.

Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).

Nephrol Dial Transplant. 2009 Jun;24(6):1819-27. doi: 10.1093/ndt/gfn744. Epub 2009 Jan 28.

引用本文的文献

Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease.

Int J Mol Sci. 2021 Jun 17;22(12):6523. doi: 10.3390/ijms22126523.

Synergistic Genetic Interactions between and Result in an ARPKD-Like Phenotype in Murine Models.

J Am Soc Nephrol. 2019 Nov;30(11):2113-2127. doi: 10.1681/ASN.2019020150. Epub 2019 Aug 19.

Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective.

Clin Kidney J. 2018 Dec;11(Suppl 1):i14-i26. doi: 10.1093/ckj/sfy088. Epub 2018 Dec 17.

Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease.

Drug Metab Dispos. 2019 Feb;47(2):155-163. doi: 10.1124/dmd.118.083907. Epub 2018 Nov 30.

The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians.

Front Pediatr. 2017 Dec 18;5:279. doi: 10.3389/fped.2017.00279. eCollection 2017.

A novel model of autosomal recessive polycystic kidney questions the role of the fibrocystin C-terminus in disease mechanism.

Kidney Int. 2017 Nov;92(5):1130-1144. doi: 10.1016/j.kint.2017.04.027. Epub 2017 Jul 18.

Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?

Pediatr Nephrol. 2018 Mar;33(3):395-408. doi: 10.1007/s00467-017-3672-x. Epub 2017 Apr 28.

Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy.

PLoS One. 2015 Jul 2;10(7):e0131677. doi: 10.1371/journal.pone.0131677. eCollection 2015.

Role of extracellular ATP and P2 receptor signaling in regulating renal cyst growth and interstitial inflammation in polycystic kidney disease.

Front Physiol. 2013 Aug 16;4:218. doi: 10.3389/fphys.2013.00218. eCollection 2013.

microRNA biomarkers in cystic diseases.

BMB Rep. 2013 Jul;46(7):338-45. doi: 10.5483/bmbrep.2013.46.7.151.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

ARPKD and ADPKD: first cousins or more distant relatives?

作者信息

Kaimori Jun-Ya, Germino Gregory G

出版信息

J Am Soc Nephrol. 2008 Mar;19(3):416-8. doi: 10.1681/ASN.2008010033. Epub 2008 Feb 13.

DOI:10.1681/ASN.2008010033

PMID:18272839

Abstract

摘要

相似文献

ARPKD and ADPKD: first cousins or more distant relatives?

J Am Soc Nephrol. 2008 Mar;19(3):416-8. doi: 10.1681/ASN.2008010033. Epub 2008 Feb 13.

Another cystic mystery solved.

Nat Genet. 2002 Mar;30(3):247-8. doi: 10.1038/ng0302-247.

Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Feb;35(2):93-9. doi: 10.3969/j.issn.1672-7347.2010.02.001.

Cilia and polycystic kidney disease.

Semin Cell Dev Biol. 2021 Feb;110:139-148. doi: 10.1016/j.semcdb.2020.05.003. Epub 2020 May 28.

Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.

J Am Soc Nephrol. 2013 Oct;24(10):1571-86. doi: 10.1681/ASN.2012111089. Epub 2013 Sep 5.

Recent advances in understanding ion transport mechanisms in polycystic kidney disease.

Clin Sci (Lond). 2021 Nov 12;135(21):2521-2540. doi: 10.1042/CS20210370.

Molecular basis of autosomal recessive polycystic kidney disease (ARPKD).

Adv Anat Pathol. 2008 Jan;15(1):54-8. doi: 10.1097/PAP.0b013e31815e5295.

Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).

Cell Tissue Res. 2006 Dec;326(3):671-85. doi: 10.1007/s00441-006-0226-0. Epub 2006 Jun 10.

Molecular genetics of ADPKD.

Contrib Nephrol. 1995;115:8-15.

Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).

Nephrol Dial Transplant. 2009 Jun;24(6):1819-27. doi: 10.1093/ndt/gfn744. Epub 2009 Jan 28.

引用本文的文献

Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease.

Int J Mol Sci. 2021 Jun 17;22(12):6523. doi: 10.3390/ijms22126523.

Synergistic Genetic Interactions between and Result in an ARPKD-Like Phenotype in Murine Models.

J Am Soc Nephrol. 2019 Nov;30(11):2113-2127. doi: 10.1681/ASN.2019020150. Epub 2019 Aug 19.

Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective.

Clin Kidney J. 2018 Dec;11(Suppl 1):i14-i26. doi: 10.1093/ckj/sfy088. Epub 2018 Dec 17.

Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease.

Drug Metab Dispos. 2019 Feb;47(2):155-163. doi: 10.1124/dmd.118.083907. Epub 2018 Nov 30.

The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians.

Front Pediatr. 2017 Dec 18;5:279. doi: 10.3389/fped.2017.00279. eCollection 2017.

A novel model of autosomal recessive polycystic kidney questions the role of the fibrocystin C-terminus in disease mechanism.

Kidney Int. 2017 Nov;92(5):1130-1144. doi: 10.1016/j.kint.2017.04.027. Epub 2017 Jul 18.

Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?

Pediatr Nephrol. 2018 Mar;33(3):395-408. doi: 10.1007/s00467-017-3672-x. Epub 2017 Apr 28.

Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy.

PLoS One. 2015 Jul 2;10(7):e0131677. doi: 10.1371/journal.pone.0131677. eCollection 2015.

Role of extracellular ATP and P2 receptor signaling in regulating renal cyst growth and interstitial inflammation in polycystic kidney disease.

Front Physiol. 2013 Aug 16;4:218. doi: 10.3389/fphys.2013.00218. eCollection 2013.

microRNA biomarkers in cystic diseases.

BMB Rep. 2013 Jul;46(7):338-45. doi: 10.5483/bmbrep.2013.46.7.151.